Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Lam, Carolyn S.; Branch, Kelley R.; Sattar, Naveed; Rosenstock, Julio; Pratley, Richard; del Prato, Stefano; Lopes, Renato D., Sr.; Niemoeller, Elisabeth; Khurmi, Nardev S.; Baek, Seungjae; Gerstein, Hertzel C.

authors

Publication Date

  • December 21, 2021

webpage

published in

category

start page

  • E584

end page

  • E584

volume

  • 144

issue

  • 25